FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003127631> ?p ?o ?g. }

• W2003127631 endingPage "235" @default.
• W2003127631 startingPage "231" @default.
• W2003127631 abstract "ObjectiveTo compare the effect of the GnRH antagonist/letrozole protocol (AL) with the microdose GnRH agonist flare-up (MF) protocol in poor ovarian responders for intracytoplasmic sperm injection (ICSI).DesignRetrospective, case-control study.SettingAnatolia Women and IVF Center.Patient(s)Eight hundred eighty-five consecutive patients (1383 cycles) predicted to have or with a history of poor ovarian response who were undergoing ICSI were enrolled. The MF protocol was used in 673 patients (1026 cycles), and the AL protocol was used in the remaining 212 patients (357 cycles).Intervention(s)Controlled ovarian hyperstimulation and ICSI.Main Outcome Measurement(s)Cycle cancellation rate, number of oocytes retrieved, fertilization rate, embryo quality, clinical pregnancy, and implantation rates.Result(s)The total gonadotropin consumption, duration of stimulation, E2 level on the day of hCG administration, and number of oocytes retrieved were significantly lower with the AL protocol compared with the MF protocol. However, the fertilization rate and the rate of at least one top-quality embryo transferred were higher with the AL compared with the MF protocol. The clinical pregnancy rates were comparable between the two groups. The implantation rates with the MF and AL protocols were 9.8% and 14.5%, respectively.Conclusion(s)The GnRH AL protocol is an effective protocol that may be used in poor ovarian responders for ICSI. To compare the effect of the GnRH antagonist/letrozole protocol (AL) with the microdose GnRH agonist flare-up (MF) protocol in poor ovarian responders for intracytoplasmic sperm injection (ICSI). Retrospective, case-control study. Anatolia Women and IVF Center. Eight hundred eighty-five consecutive patients (1383 cycles) predicted to have or with a history of poor ovarian response who were undergoing ICSI were enrolled. The MF protocol was used in 673 patients (1026 cycles), and the AL protocol was used in the remaining 212 patients (357 cycles). Controlled ovarian hyperstimulation and ICSI. Cycle cancellation rate, number of oocytes retrieved, fertilization rate, embryo quality, clinical pregnancy, and implantation rates. The total gonadotropin consumption, duration of stimulation, E2 level on the day of hCG administration, and number of oocytes retrieved were significantly lower with the AL protocol compared with the MF protocol. However, the fertilization rate and the rate of at least one top-quality embryo transferred were higher with the AL compared with the MF protocol. The clinical pregnancy rates were comparable between the two groups. The implantation rates with the MF and AL protocols were 9.8% and 14.5%, respectively. The GnRH AL protocol is an effective protocol that may be used in poor ovarian responders for ICSI." @default.
• W2003127631 created "2016-06-24" @default.
• W2003127631 creator A5033723894 @default.
• W2003127631 creator A5045718012 @default.
• W2003127631 creator A5056788801 @default.
• W2003127631 creator A5062347287 @default.
• W2003127631 creator A5086296039 @default.
• W2003127631 date "2009-07-01" @default.
• W2003127631 modified "2023-10-03" @default.
• W2003127631 title "Antagonist/letrozole protocol in poor ovarian responders for intracytoplasmic sperm injection: a comparative study with the microdose flare-up protocol" @default.
• W2003127631 cites W1963606316 @default.
• W2003127631 cites W1964563527 @default.
• W2003127631 cites W1971432112 @default.
• W2003127631 cites W1974588053 @default.
• W2003127631 cites W1985558029 @default.
• W2003127631 cites W1990913605 @default.
• W2003127631 cites W1991746016 @default.
• W2003127631 cites W1993816409 @default.
• W2003127631 cites W1995071598 @default.
• W2003127631 cites W2001051801 @default.
• W2003127631 cites W200566278 @default.
• W2003127631 cites W2014686801 @default.
• W2003127631 cites W2015325021 @default.
• W2003127631 cites W2022889910 @default.
• W2003127631 cites W2030724156 @default.
• W2003127631 cites W2061350520 @default.
• W2003127631 cites W2105251513 @default.
• W2003127631 cites W2114124243 @default.
• W2003127631 cites W2115337926 @default.
• W2003127631 cites W2132173246 @default.
• W2003127631 cites W2347038159 @default.
• W2003127631 cites W2415017659 @default.
• W2003127631 cites W4236627566 @default.
• W2003127631 doi "https://doi.org/10.1016/j.fertnstert.2008.04.057" @default.
• W2003127631 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18678368" @default.
• W2003127631 hasPublicationYear "2009" @default.
• W2003127631 type Work @default.
• W2003127631 sameAs 2003127631 @default.
• W2003127631 citedByCount "75" @default.
• W2003127631 countsByYear W20031276312012 @default.
• W2003127631 countsByYear W20031276312013 @default.
• W2003127631 countsByYear W20031276312014 @default.
• W2003127631 countsByYear W20031276312015 @default.
• W2003127631 countsByYear W20031276312016 @default.
• W2003127631 countsByYear W20031276312017 @default.
• W2003127631 countsByYear W20031276312018 @default.
• W2003127631 countsByYear W20031276312019 @default.
• W2003127631 countsByYear W20031276312020 @default.
• W2003127631 countsByYear W20031276312021 @default.
• W2003127631 countsByYear W20031276312022 @default.
• W2003127631 countsByYear W20031276312023 @default.
• W2003127631 crossrefType "journal-article" @default.
• W2003127631 hasAuthorship W2003127631A5033723894 @default.
• W2003127631 hasAuthorship W2003127631A5045718012 @default.
• W2003127631 hasAuthorship W2003127631A5056788801 @default.
• W2003127631 hasAuthorship W2003127631A5062347287 @default.
• W2003127631 hasAuthorship W2003127631A5086296039 @default.
• W2003127631 hasBestOaLocation W20031276311 @default.
• W2003127631 hasConcept C121608353 @default.
• W2003127631 hasConcept C126322002 @default.
• W2003127631 hasConcept C16685009 @default.
• W2003127631 hasConcept C2776166826 @default.
• W2003127631 hasConcept C2776537878 @default.
• W2003127631 hasConcept C2777702977 @default.
• W2003127631 hasConcept C2778278907 @default.
• W2003127631 hasConcept C2778478619 @default.
• W2003127631 hasConcept C2778812593 @default.
• W2003127631 hasConcept C2779234561 @default.
• W2003127631 hasConcept C2780913584 @default.
• W2003127631 hasConcept C2781230225 @default.
• W2003127631 hasConcept C29456083 @default.
• W2003127631 hasConcept C512716672 @default.
• W2003127631 hasConcept C530470458 @default.
• W2003127631 hasConcept C54355233 @default.
• W2003127631 hasConcept C71315377 @default.
• W2003127631 hasConcept C71924100 @default.
• W2003127631 hasConcept C86803240 @default.
• W2003127631 hasConceptScore W2003127631C121608353 @default.
• W2003127631 hasConceptScore W2003127631C126322002 @default.
• W2003127631 hasConceptScore W2003127631C16685009 @default.
• W2003127631 hasConceptScore W2003127631C2776166826 @default.
• W2003127631 hasConceptScore W2003127631C2776537878 @default.
• W2003127631 hasConceptScore W2003127631C2777702977 @default.
• W2003127631 hasConceptScore W2003127631C2778278907 @default.
• W2003127631 hasConceptScore W2003127631C2778478619 @default.
• W2003127631 hasConceptScore W2003127631C2778812593 @default.
• W2003127631 hasConceptScore W2003127631C2779234561 @default.
• W2003127631 hasConceptScore W2003127631C2780913584 @default.
• W2003127631 hasConceptScore W2003127631C2781230225 @default.
• W2003127631 hasConceptScore W2003127631C29456083 @default.
• W2003127631 hasConceptScore W2003127631C512716672 @default.
• W2003127631 hasConceptScore W2003127631C530470458 @default.
• W2003127631 hasConceptScore W2003127631C54355233 @default.
• W2003127631 hasConceptScore W2003127631C71315377 @default.
• W2003127631 hasConceptScore W2003127631C71924100 @default.
• W2003127631 hasConceptScore W2003127631C86803240 @default.
• W2003127631 hasIssue "1" @default.
• W2003127631 hasLocation W20031276311 @default.

• next